The United States and Tajikistan have signed a five-year bilateral health cooperation Memorandum of Understanding (MOU), marking the first such MOU concluded under the Trump Administration’s America First Global Health Strategy (AFGHS) in South and Central Asia, according to the U.S. Embassy in Dushanbe.
Working with Congress, the Department of State intends to provide $38 million in U.S. global health assistance through this bilateral health MOU through Fiscal Year 2030, while Tajikistan has committed to increasing its own domestic expenditures by $40 million over the duration of the health MOU.
This jointly decided $78 million MOU will support Tajikistan’s efforts to combat HIV, tuberculosis (TB), and strengthen global health security through the identification and containment of infectious diseases. Joint activities planned under this bilateral health MOU support the Government of Tajikistan’s plan to build a fully integrated national system to detect, report, and respond to outbreaks, allowing Tajikistan to detect infectious disease events with epidemic or pandemic potential within seven days, notify relevant national authorities and the U.S. government within one day, and initiate an evidence-based response within seven days. This system will integrate all major disease surveillance and laboratory networks into a unified architecture. The five-year MOU will support the integration of surveillance, laboratory, and health data systems into real-time, secure, and interoperable platforms.
The Government of Tajikistan will progressively assume responsibility for its own health system funding by retaining a stable health workforce, including clinicians, epidemiologists, laboratorians, and data specialists, to ensure high-quality diagnostics, clinical services, and timely outbreak detection in Tajikistan. The bilateral health MOU will promote the deployment of cutting-edge digital health solutions, including AI-assisted screening tools, electronic reporting, and interoperable data platforms.
By pairing U.S. technical expertise and targeted investment with robust Tajik co-financing and reform commitments, the MOU strengthens Tajik prevention and response to infectious diseases like HIV and TB while advancing U.S. economic and public health security interests.
